| 000 | 01833 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516142109.0 | ||
| 264 | 0 | _c20130918 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a0151-9638 | ||
| 024 | 7 |
_a10.1016/S0151-9638(12)70128-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRendon, M | |
| 245 | 0 | 0 |
_aTopical treatment of hyperpigmentation disorders. _h[electronic resource] |
| 260 |
_bAnnales de dermatologie et de venereologie _cDec 2012 |
||
| 300 |
_aS153-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aArbutin _xadministration & dosage |
| 650 | 0 | 4 |
_aChromones _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xadministration & dosage |
| 650 | 0 | 4 |
_aGlucosides _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroquinones _xtherapeutic use |
| 650 | 0 | 4 |
_aHyperpigmentation _xdrug therapy |
| 650 | 0 | 4 |
_aKeratolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aMonophenol Monooxygenase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 | _aPhytotherapy |
| 650 | 0 | 4 |
_aPlant Preparations _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReceptor, PAR-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRetinoids _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aSkin Lightening Preparations _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin Pigmentation _xdrug effects |
| 700 | 1 | _aHorwitz, S | |
| 773 | 0 |
_tAnnales de dermatologie et de venereologie _gvol. 139 Suppl 4 _gp. S153-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0151-9638(12)70128-X _zAvailable from publisher's website |
| 999 |
_c22608539 _d22608539 |
||